{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:43:07Z","timestamp":1762101787037,"version":"3.40.3"},"publisher-location":"New York, NY","reference-count":7,"publisher":"Springer New York","isbn-type":[{"type":"print","value":"9781493932511"},{"type":"electronic","value":"9781493932528"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3252-8_4","type":"book-chapter","created":{"date-parts":[[2015,12,13]],"date-time":"2015-12-13T05:07:07Z","timestamp":1449983227000},"page":"29-37","source":"Crossref","is-referenced-by-count":13,"title":["Simultaneous Quantitation of Lamotrigine, Levetiracetam, 10-Hydroxycarbazepine, Topiramate, and Zonisamide in Serum Using HPLC-MS\/MS"],"prefix":"10.1007","author":[{"given":"Dean C.","family":"Carlow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan C.","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"s9","key":"4_CR1","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1111\/j.1528-1157.1999.tb02090.x","volume":"40","author":"SC Schachter","year":"1999","unstructured":"Schachter SC (1999) Antiepileptic drug therapy: general treatment principles and application for special patient populations. Epilepsia 40(s9):S20\u2013S25","journal-title":"Epilepsia"},{"issue":"11","key":"4_CR2","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1515\/CCLM.2004.245","volume":"42","author":"HM Neels","year":"2004","unstructured":"Neels HM et al (2004) Therapeutic drug monitoring of old and newer anti-epileptic drugs. Clin Chem Lab Med 42(11):1228\u20131255","journal-title":"Clin Chem Lab Med"},{"issue":"7","key":"4_CR3","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","volume":"49","author":"PN Patsalos","year":"2008","unstructured":"Patsalos PN et al (2008) Antiepileptic drugs\u2014best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 49(7):1239\u20131276","journal-title":"Epilepsia"},{"issue":"3","key":"4_CR4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/00007691-200306000-00016","volume":"25","author":"SI Johannessen","year":"2003","unstructured":"Johannessen SI et al (2003) Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 25(3):347\u2013363","journal-title":"Ther Drug Monit"},{"issue":"11","key":"4_CR5","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.2165\/00003088-200645110-00002","volume":"45","author":"SI Johannessen","year":"2006","unstructured":"Johannessen SI, Tomson T (2006) Pharmacokinetic variability of newer antiepileptic drugs. Clin Pharmacokinet 45(11):1061\u20131075","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"4_CR6","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2165\/00003088-200038030-00001","volume":"38","author":"E Perucca","year":"2000","unstructured":"Perucca E (2000) Is there a role for therapeutic drug monitoring of new anticonvulsants. Clin Pharmacokinet 38(3):191\u2013204","journal-title":"Clin Pharmacokinet"},{"issue":"6","key":"4_CR7","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.3390\/ph3061908","volume":"3","author":"MD Krasowski","year":"2010","unstructured":"Krasowski MD (2010) Therapeutic drug monitoring of the newer anti-epilepsy medications. Pharmaceuticals 3(6):1909\u20131935","journal-title":"Pharmaceuticals"}],"container-title":["Methods in Molecular Biology","Clinical Applications of Mass Spectrometry in Drug Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3252-8_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,15]],"date-time":"2023-02-15T19:10:51Z","timestamp":1676488251000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-4939-3252-8_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493932511","9781493932528"],"references-count":7,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3252-8_4","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"type":"print","value":"1064-3745"},{"type":"electronic","value":"1940-6029"}],"subject":[],"published":{"date-parts":[[2016]]}}}